The DOI matches its Crossref record; 40 of the 42 references it cites were found in a registry or an index.
Glycemic Outcome Associated With Insulin Pump and Glucose Sensor Use in Children and Adolescents With Type 1 Diabetes. Data From the International Pediatric Registry SWEET
Abstract
OBJECTIVE: Insulin delivery methods, glucose-monitoring modalities, and related outcomes were examined in a large, international, diverse cohort of children and adolescents with type 1 diabetes from the Better Control in Pediatric and Adolescent Diabetes: Working to Create Centers of Reference (SWEET) -Registry. RESEARCH DESIGN AND METHODS: Participants with type 1 diabetes of ≥1 year, aged ≤18 years, and who had documented pump or sensor usage during the period August 2017–July 2019 were stratified into four categories: injections–no sensor (referent); injections + sensor; pump–no sensor; and pump + sensor. HbA1c and proportion of patients with diabetic ketoacidosis (DKA) or severe hypoglycemia (SH) were analyzed; linear and logistic regression models adjusted for demographics, region, and gross domestic product per capita were applied. RESULTS: Data of 25,654 participants were analyzed. The proportions of participants (adjusted HbA1c data) by study group were as follows: injections–no sensor group, 37.44% (8.72; 95% CI 8.68–8.75); injections + sensor group, 14.98% (8.30; 95% CI 8.25–8.35); pump–no sensor group, 17.22% (8.07; 95% CI 8.03–8.12); and pump + sensor group, 30.35% (7.81; 95% CI 7.77–7.84). HbA1c was lower in all categories of participants who used a pump and/or sensor compared with the injections–no sensor treatment method (P < 0.001). The proportion of DKA episodes was lower in participants in the pump + sensor (1.98%; 95% CI 1.64–2.48; P < 0.001) and the pump–no sensor (2.02%; 95% CI 1.64–2.48; P < 0.05) groups when compared with those in the injections–no sensor group (2.91%; 95% CI 2.59–3.31). The proportion of participants experiencing SH was lower in pump–no sensor group (1.10%; 95% CI 0.85–1.43; P < 0.001) but higher in the injections + sensor group (4.25%; 95% CI 3.65–4.95; P < 0.001) compared with the injections–no sensor group (2.35%; 95% CI 2.04–2.71). CONCLUSIONS: Lower HbA1c and fewer DKA episodes were observed in participants using either a pump or continuous glucose monitoring (CGM) or both. Pump use was associated with a lower rate of SH. Across SWEET centers, use of pumps and CGM is increasing. The concomitant use of pump and CGM was associated with an additive benefit.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In comparisons of regimens of MDI with BGM (without CGM) vs CSII for T1D, there have been small improvements in A1C, but substantial reductions in severe and nocturnal hypoglycemia.1113,1125–1127”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1125]
In the citing paper
“Compared to capillary blood glucose monitoring, real-time continuous glucose monitoring has been shown to consistently improve glycaemic metrics in children,14 adolescents15 and adults,16 including older adults,17 with type 1 diabetes.”
From Blood glucose monitoring devices: current considerations (2023) · cites this paper as [14]
In the citing paper
“Besides advantages in increasing comfort, for example by enabling uninterrupted physical activity and minimizing the need for capillary glucose tests, better glycemic control has been shown in several studies. 7 , 13 , 19 , 20 , 21”
In the citing paper
“However, studies have shown mixed results regarding DKA incidence rates when comparing CSII with MDI. CSII has been associated with higher, 10 , 11 lower, 7 , 8 or practically equal 12 , 13 DKA incidence rates compared with MDI in various populations.”
In the citing paper
“CGM has been associated with lower frequencies of DKA in several international studies. 7”
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018
Foster, N. C., Beck, R. W., Miller, K. M., Clements, M. A., Rickels, M. R., DiMeglio, L. A., Maahs, D. M., Tamborlane, W. V., Bergenstal, R., Smith, E., et al. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0384 · Cited by 1,907
Wolfsdorf, J. I., Glaser, N., Agus, M., Fritsch, M., Hanas, R., Rewers, A., Sperling, M. A., & Codner, E. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12701 · Cited by 710
DiMeglio, L. A., Acerini, C. L., Codner, E., Craig, M. E., Hofer, S. E., Pillay, K., & Maahs, D. M. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12737 · Cited by 604
Pickup, J. C., Freeman, S. C., & Sutton, A. J. (2011) · BMJ · doi:10.1136/bmj.d3805 · Cited by 541
Karges, B., Schwandt, A., Heidtmann, B., Kordonouri, O., Binder, E., Schierloh, U., Boettcher, C., Kapellen, T., Rosenbauer, J., & Holl, R. W. (2017) · JAMA · doi:10.1001/jama.2017.13994 · Cited by 452
Self-citationMisso, M. L., Egberts, K. J., Page, M., O'Connor, D., & Shaw, J. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005103.pub2 · Cited by 406
Assessment and monitoring of glycemic control in children and adolescents with diabetes
Rewers, M. J., Pillay, K., de Beaufort, C., Craig, M. E., Hanas, R., Acerini, C. L., & Maahs, D. M. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12190 · Cited by 316
Šoupal, J., Petruželková, L., Grunberger, G., Hásková, A., Flekač, M., Matoulek, M., Mikeš, O., Pelcl, T., Škrha, J., Horová, E., et al. (2020) · Diabetes Care · doi:10.2337/dc19-0888 · Cited by 242
for the T1D Exchange Clinic Network, T. D. I., Sherr, J. L., Hermann, J. M., Campbell, F., Foster, N. C., Hofer, S. E., Allgrove, J., Maahs, D. M., Kapellen, T. M., Holman, N., et al. (2016) · Diabetologia · doi:10.1007/s00125-015-3790-6 · Cited by 237
DeSalvo, D. J., Miller, K. M., Hermann, J. M., Maahs, D. M., Hofer, S. E., Clements, M. A., Lilienthal, E., Sherr, J. L., Tauschmann, M., Holl, R. W., et al. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12711 · Cited by 233
Abraham, M. B., Jones, T. W., Naranjo, D., Karges, B., Oduwole, A., Tauschmann, M., & Maahs, D. M. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12698 · Cited by 226
Maahs, D. M., Hermann, J. M., Holman, N., Foster, N. C., Kapellen, T. M., Allgrove, J., Schatz, D. A., Hofer, S. E., Campbell, F., Steigleder-Schweiger, C., et al. (2015) · Diabetes Care · doi:10.2337/dc15-0780 · Cited by 224
ISPAD Clinical Practice Consensus Guidelines 2018: diabetes technologies
Sherr, J. L., Tauschmann, M., Battelino, T., de Bock, M., Forlenza, G., Roman, R., Hood, K. K., & Maahs, D. M. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12731 · Cited by 197
van den Boom, L., Karges, B., Auzanneau, M., Rami-Merhar, B., Lilienthal, E., von Sengbusch, S., Datz, N., Schröder, C., Kapellen, T., Laimer, M., et al. (2019) · Diabetes Care · doi:10.2337/dc19-0345 · Cited by 191
Weinzimer, S. A., Ahern, J. H., Doyle, E. A., Vincent, M. R., Dziura, J., Steffen, A. T., & Tamborlane, W. V. (2004) · Pediatrics · doi:10.1542/peds.2004-0092 · Cited by 166
Johnson, S. R., Cooper, M. N., Davis, E. A., & Jones, T. W. (2013) · Diabetic Medicine · doi:10.1111/dme.12247 · Cited by 158
Insulin pump therapy in children with type 1 diabetes: analysis of data from the SWEET registry
Szypowska, A., Schwandt, A., Svensson, J., Shalitin, S., Cardona‐Hernandez, R., Forsander, G., Sundberg, F., de Beaufort, C. E., Maahs, D. M., Maffeis, C., et al. (2016) · Pediatric Diabetes · doi:10.1111/pedi.12416 · Cited by 140
Self-citationConsensus Committee (2007) · Diabetologia · doi:10.1007/s00125-007-0789-7 · Cited by 134
Hanas, R., Lindgren, F., & Lindblad, B. (2009) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2008.00441.x · Cited by 129
Hermann, J. M., Miller, K. M., Hofer, S. E., Clements, M. A., Karges, W., Foster, N. C., Fröhlich-Reiterer, E. E., Rickels, M. R., Rosenbauer, J., DeSalvo, D. J., et al. (2019) · Diabetic Medicine · doi:10.1111/dme.14148 · Cited by 124
Charalampopoulos, D., Hermann, J. M., Svensson, J., Skrivarhaug, T., Maahs, D. M., Åkesson, K., Warner, J., Holl, R. W., Birkebæk, N., Drivvoll, A. K., et al. (2018) · Diabetes Care · doi:10.2337/dc17-2271 · Cited by 114
Tauschmann, M., Hermann, J. M., Freiberg, C., Papsch, M., Thon, A., Heidtmann, B., Placzek, K., Agena, D., Kapellen, T. M., Schenk, B., et al. (2020) · Diabetes Care · doi:10.2337/dc19-1358 · Cited by 114
Schwandt, A., Hermann, J. M., Rosenbauer, J., Boettcher, C., Dunstheimer, D., Grulich‐Henn, J., Kuß, O., Rami-Merhar, B. M., Vogel, C., Holl, R. W., et al. (2016) · Diabetes Care · doi:10.2337/dc16-1625 · Cited by 103
Self-citationMiller, K. M., Hermann, J. M., Foster, N. C., Hofer, S. E., Rickels, M. R., Danne, T., Clements, M. A., Lilienthal, E., Maahs, D. M., Holl, R. W., et al. (2019) · Diabetes Care · doi:10.2337/dc19-1214 · Cited by 96
Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus
Siebenhofer, A., Plank, J., Berghold, A., Narath, M., Gfrerer, R., & Pieber, T. R. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003287.pub3 · Cited by 72
Pettus, J., Price, D. A., & Edelman, S. V. (2015) · Endocrine Practice · doi:10.4158/ep14520.or · Cited by 68
Auzanneau, M., Lanzinger, S., Bohn, B., Kroschwald, P., Kuhnle-Krahl, U., Holterhus, P., Placzek, K., Hamann, J., Bachran, R., Rosenbauer, J., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0724 · Cited by 60
Mönkemöller, K., Müller–Godeffroy, E., Lilienthal, E., Heidtmann, B., Becker, M., Feldhahn, L., Freff, M., Hilgard, D., Krone, B., Papsch, M., et al. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12847 · Cited by 57
Haynes, A., Hermann, J. M., Clapin, H. F., Hofer, S. E., Karges, B., Jones, T. W., Davis, E. A., & Holl, R. W. (2019) · Diabetes Care · doi:10.2337/dc18-2448 · Cited by 54
Witsch, M., Kosteria, I., Kordonouri, O., Alonso, G. T., Archinkova, M., Besançon, S., Birkebæk, N., Bratina, N., Cherubini, V., Hanås, R., et al. (2016) · Pediatric Diabetes · doi:10.1111/pedi.12432 · Cited by 52
Self-citationŠumník, Z., Szypowska, A., Iotova, V., Bratina, N., Cherubini, V., Forsander, G., Jali, S. M., Raposo, J. F., Stipančić, G., Vazeou, A., et al. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12833 · Cited by 51
Nielsen, N. F., Gaulke, A., Eriksen, T. L. M., Svensson, J., & Skipper, N. (2019) · Diabetes Care · doi:10.2337/dc19-0184 · Cited by 46
Prahalad, P., Addala, A., Buckingham, B. A., Wilson, D. M., & Maahs, D. M. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0204 · Cited by 42
Criteria for Centers of Reference for pediatric diabetes - a European perspective
Danne, T., Lion, S., Madaczy, L., Veeze, H. J., Raposo, F., Rurik, I., Aschemeier, B., Kordonouri, O., & the SWEET group (2012) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2012.00914.x · Cited by 35
Pediatric Medicaid Patients With Type 1 Diabetes Benefit From Continuous Glucose Monitor Technology
Ravi, S., Coakley, A., Vigers, T., Pyle, L. L., Forlenza, G. P., & Alonso, T. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820906214 · Cited by 29
Gajewska, K. A., Bennett, K., Biesma, R. G., & Sreenan, S. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-00573-w · Cited by 24
Type 1 diabetes during adolescence: International comparison between Germany, Austria, and Sweden
Hanberger, L., Samuelsson, U., Holl, R. W., Fröhlich-Reiterer, E. E., Åkesson, K., & Hofer, S. E. (2017) · Pediatric Diabetes · doi:10.1111/pedi.12591 · Cited by 22
20 Years of insulin lispro in pediatric type 1 diabetes: a review of available evidence
Kaiserman, K. B., Jung, H., Benabbad, I., Karges, B., Polak, M., & Rosilio, M. (2016) · Pediatric Diabetes · doi:10.1111/pedi.12401 · Cited by 19
Center Size and Glycemic Control: An International Study With 504 Centers From Seven Countries
Birkebæk, N., Hermann, J. M., Hanberger, L., Charalampopoulos, D., Holl, R. W., Skrivarhaug, T., Aakesson, K., Warner, J., Drivvoll, A. K., Svensson, J., et al. (2019) · Diabetes Care · doi:10.2337/dc18-1253 · Cited by 14
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Teplizumab and β-cell function in newly diagnosed type 1 diabetes
Ramos, E. L., Dayan, C. M., Chatenoud, L., Sumnik, Z., Simmons, K. M., Szypowska, A., Gitelman, S. E., Knecht, L. A., Niemoeller, E., Tian, W., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2308743 · Cited by 273
Arrieta, A., Battelino, T., Scaramuzza, A. E., Silva, J. D., Castañeda, J., Cordero, T. L., Shin, J., & Cohen, O. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14714 · Cited by 172
ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Insulin delivery
Sherr, J. L., Schoelwer, M., Dos Santos, T. J., Reddy, L., Biester, T., Galderisi, A., van Dyk, J. C., Hilliard, M. E., Berget, C., & DiMeglio, L. A. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13421 · Cited by 152
McCall, A. L., Lieb, D. C., Gianchandani, R. Y., MacMaster, H. W., Maynard, G. A., Murad, M. H., Seaquist, E. R., Wolfsdorf, J. I., Wright, R. F., & Wiercioch, W. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac596 · Cited by 146
Metadata
- Authors
- Cardona-Hernandez, R., Schwandt, A., Alkandari, H., Bratke, H., Chobot, A., Coles, N., Corathers, S., Goksen, D., Goss, P., Imane, Z., Nagl, K., O’Riordan, S. M. P., & Jefferies, C.
- Affiliations
- Division of Pediatric Endocrinology, Hospital Sant Joan de Déu, Barcelona, Spain
- Universität Ulm (DE)
- Dasman Diabetes Institute (KW)
- Fonna Hospital Trust (NO)
- University of Opole (PL)
- Markham Stouffville Hospital (CA)
- Cincinnati Children's Hospital Medical Center (US)
- Faculty of Medicine, Pediatric Endocrinology and Diabetes, Ege University, İzmir, Turkey
- Team Diabetes, Geelong, Victoria, Australia
- Mohammed V University (MA)
- Medical University of Vienna (AT)
- Cork University Hospital (IE)
- Starship Children's Health (NZ)
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2021-03-02
- Volume
- 44
- Issue
- 5
- Pages
- 1176-1184
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W3134137658
- Cited by
- 129
- References
- 42
- Citations by year
- 2026: 14 · 2025: 22 · 2024: 20 · 2023: 30 · 2022: 26 · 2021: 17
- FWCI
- 17.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- type 1 diabetes, insulin pump therapy, continuous glucose monitoring, HbA1c, glycemic control, diabetic ketoacidosis, severe hypoglycemia, children and adolescents, insulin delivery method, diabetes complications, diabetes-related hospitalization
- MeSH terms
- Adolescent, Blood Glucose, Child, Diabetes Mellitus, Type 1, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Insulin, Insulin Infusion Systems, Registries, Blood Glucose Self-Monitoring
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.